DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) announced the appointment of Karen Katen to its board of directors, effective today. A senior pharmaceutical industry executive at Pfizer for more than three decades, Karen retired in 2007 as vice chairman of Pfizer Inc. and president of Pfizer Human Health. “We are very fortunate to have Karen join our board,” said Ari Bousbib, IMS Health chairman and CEO. “Her extensive experience in life sciences, strong commitment to improving public he
| < Prev | Next > |
|---|
